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Abstract
Millions of hand, foot and mouth disease cases occur annually and
the disease is considered a significant public health threat in China.
We have focused on Linyi for 3 years to analyse the aetiological
spectrum and epidemic changes. The reported number of cases of
HFMD in Linyi declined in 2011,with the percentage of HEV71
dropping to 11%. Although CVA16 rose to 51% in 2011, the
number of CVA16 cases did not change significantly compared
with the previous 2 years. Other types of enteroviruses were
detected in 2011 and might play more important roles in future
epidemics.
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Hand, foot and mouth disease (HFMD) is a common infectious
illness in young children, particularly those aged <5 years.
Human enteroviruses (HEVs), particularly those belonging to
species A, are the aetiological agents involved in most cases of
HFMD. In particular, human enterovirus 71 (HEV71), cox-
sackie virus A16 (CVA16) and coxsackie virus A6 (CVA6)
cause most of the epidemics worldwide (1).
In mainland China, prior to 2007, HFMD epidemics usually
only occurred in southern areas, such as in Guangdong
province about 10 years ago (2). However, in 2007, a
large-scale HFMD outbreak was reported in Linyi, Shandong
Province, with thousands of cases and three deaths reported
(3). Since then, HFMD has spread to most parts of the nation,
resulting in millions of infections and hundreds of deaths
annually. HFMD is currently considered a significant public
health threat in China.
As the first large-scale outbreak site and an area with a
continuing endemic, Linyi is located in the central plains of
mainland China and is a large transportation centre. From
2009 to 2011, we focused on Linyi to analyse the HFMD
aetiological spectrum and the epidemic changes, so as to assess
the relative frequency of enterovirus infections and to inform
future surveillance studies and vaccine development at the
national level.
From 2009 to 2011, 352 throat swabs were collected from
HFMD inpatients in Linyi People’s Hospital (110–120 samples
per year). All patients were identified according to the Ministry
of Health diagnostic criteria (http://www.moh.gov.cn/
mohjbyfkzj/s3577/200805/34775.shtml; Chinese website).
Samples were characterized by semi-nested RT-PCR on the
5′ partial region of VP1 as previously described (4), and 287
enterovirus-positive results were sequenced for phylogenetic
analysis. Thirty-seven sequences were submitted to Genbank
(Genbank Accession Numbers: JQ713864-JQ713900).
As shown in Fig. 1 and Table 1, in the large epidemics in
both 2009 and 2010 (14 697 cases in 2009 and 12 942 cases in
FIG. 1. The number of HFMD cases reported (right axis) and the
proportion of different enterovirus serotypes isolated (left axis) in
Linyi, China, 2009–2011. Note that the reported HFMD case numbers
corresponding to the numbers on the right axis came from the
National Notifiable Diseases Reporting System, China CDC.
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2010), HEV71 accounted for a large proportion of the positive
samples identified ( 63% and 82% of positive cases, respec-
tively). CVA16 accounted for only 16% and 15% and other
enteroviruses accounted for 21% and 3%, respectively. How-
ever, the aetiological spectrum changed significantly in 2011,
with a substantial decline in HFMD cases (3126 cases). HEV71
was identified in only 11% of the positive cases and CVA16
accounted for 51%. The percentage of other enteroviruses
also rose to 38%, with more types detected, including CVA6
(6%), CVA12 (10%) and Echovirus 30 (5%), or CVA4 (6%),
CVA2 (1%), CVB1 (3%), CVB4 (1%) and Echovirus 6 (1%),
which were only detected in 2011. CVB5 accounted for 14% in
2009, but was not isolated in 2010 or 2011. Nine samples (four
in 2009 and five in 2011) were co-detected with CVA16 and
one or two other types of enterovirus (CVB5 and CVA6).
Since 2007, epidemic waves of HFMD initiating from Linyi
have swept across most parts of the central plains of China (3).
Most reports showed that HEV71 was the main pathogen.
Consistent with previous reports, phylogenetic analysis
showed that all identified HEV71 strains in our study belonged
to subgenogroup C4 (5). Notably, HEV71 was no longer the
dominant virus strain of HFMD in Linyi in 2011; at the same
time there was a significant decline in the number of HFMD
cases reported. With HEV71 declining in 2011, we noted that
infections caused by other enterovirus species increased
(Table 1), with CVA16 becoming the dominant strain (51%)
in 2011. All CVA16 strains detected in this study grouped with
cluster B1a, consistent with Chinese CVA16 strains isolated
between 1999 and 2008, which were also found in Taiwan,
Malaysia, Thailand, Australia, Vietnam and Saudi Arabia (6).
Except for HEV71 and CVA16, other enteroviruses might
play more important roles in future epidemics. There has been
increasing reports worldwide of HFMD outbreaks caused by
other enteroviruses in recent years. CVA6 was identified as
the aetiological agent of HFMD outbreaks in Finland (7), Spain
(8), Japan (9) and Taiwan (10). Some HFMD outbreaks and
sporadic cases also have been associated with CVA10, which
was predominant in 2004, 2007 and 2009 in Taiwan (11), and in
Japan in 2007 (12). CVA12 (13), CVB1 (8) and CVB5 (14) have
also been reported to be associated with HFMD. We also
detected these HEVs in our study.
Our data indicated that the large HFMD outbreaks that have
occurred since 2007 in Linyi were mainly due to HEV71 C4, and
with the gradually formed immune barrier to viruses, the
HFMD epidemic substantially declined. The higher proportion
(51%) of CVA16 in 2011 did not mean the ascent of a CVA16
epidemic. It seemed to be only a reflection of the decline of
HEV71, because there was no significant change in absolute
numbers of CVA16 cases compared with 2009 and 2010. With
the number of newborns increasing and the immune barriers
quickly fading, the epidemic of HFMD might rise again.
Therefore, developing a vaccine against HEV71 should be very
important for prevention and control of HFMD in China.
Meanwhile, other enteroviruses should also be investigated as
they are likely to become the next mainstream pathogens and
cause new epidemic waves of HEV infections in the future.
Currently, only HEV71 and CVA16 are identified and
reported at the national level of HFMD surveillance in China.
Our study provides a relatively accurate picture of the
aetiological spectrum of HFMD in Linyi, and found that it
was complex and changeable. These data indicate a recent
decline in HEV71 and the change in the overall circulation of
other HEVs. This might suggest a higher nationwide prevalence
of HEVs, with the exception of HEV71, in the future. Besides
HEV71 and CVA16, prospective diagnosis combined with
genotyping yielded consistent epidemiological data regarding
other HEVs and should be considered in the management of
future national outbreaks.
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TABLE 1. Enteroviral serotypes isolated from HFMD cases
in Linyi, China, 2009–2011
Enteroviral types
Number of isolates
2009 2010 2011
CVA
HEV71 63 79 10
CVA16 16 14 46
CVA6 2 1 5
CVA4 5
CVA12 3 9
CVA2 1
CVA10 2
CVB
CVB1 3
CVB4 1
ECHO6 1
ECHO25 1
ECHO30 1 4
CVA9 1
CVB5 10
Co-detected
CVA16/B5 3
Enterovirus
CVA16/B5/A6 1
CVA16/B1 1
CVA16/echo30 3
CVA16/B4 1
Total 100 97 90
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